• Ranitidine cancer risk. Recall of ranitidine drug/
    Pharmacy insights

    Ranitidine recalls: updates & patients information

    The global market for ranitidine has been in turmoil in recent months, due to number of ranitidine recalls (including branded Zantac) by The U.S. Food and Drug Administration (FDA) in the US and shortly afterward, in UK. The Medicines and Healthcare Regulatory Agency (MHRA) recalled number of ranitidine products due to possible contamination with N-nitrosodimethylamine (NDMA), which has genotoxic and carcinogenic potential, a substance that could possibly cause cancer. Ranitidine – cancer scare was born. Note: Ranitidine (the chemical) does not have carcinogenic potential, but NDMA, a contaminant, which was found in many ranitidine containing products (tablets). Ranitidine is a commonly prescribed medication used mainly for the treatment of acid…